David Jin Biography and Net Worth

Director of Mustang Bio

Mr. Jin has served as a member of our Board of Directors since October 2024. He also serves as Chief Financial Officer and Head of Corporate Development at Fortress Biotech, and as Interim Chief Financial Officer and Chief Operating Officer of Avenue Therapeutics. Previously, he was on the investment team in the Private Equity & Real Assets group at Barings, Director of Corporate Development at Sorrento Therapeutics, Vice President of Healthcare Investment Banking at FBR & Co., and was in the management consulting group at IMS Health (now IQVIA). He holds a B.S. in Industrial Engineering & Management Sciences with a double-major in Mathematical Methods in the Social Sciences from Northwestern University.

What is David Jin's net worth?: The estimated net worth of David Jin is at least $123.04 as of December 30th, 2025. Mr. Jin owns 286 shares of Mustang Bio stock worth more than $123 as of October 9th. This net worth approximation does not reflect any other assets that Mr. Jin may own. Learn More about David Jin's net worth.
How do I contact David Jin?: The corporate mailing address for Mr. Jin and other Mustang Bio executives is 95 Sawyer RD, Suite 110, Waltham, MA, 02453. Mustang Bio can also be reached via phone at (781) 652-4500 and via email at [email protected]. Learn More on David Jin's contact information.
Has David Jin been buying or selling shares of Mustang Bio?: David Jin has not been actively trading shares of Mustang Bio during the last quarter. Most recently, on Tuesday, December 30th, David Jin bought 247 shares of Mustang Bio stock. The stock was acquired at an average cost of $0.96 per share, with a total value of $237.12. Following the completion of the transaction, the director now directly owns 286 shares of the company's stock, valued at $274.56. Learn More on David Jin's trading history.
Who are Mustang Bio's active insiders?: Mustang Bio's insider roster includes Brian Achenbach (SVP), Adam Chill (Director), David Jin (Director), and Manuel Litchman (CEO). Learn More on Mustang Bio's active insiders.
Are insiders buying or selling shares of Mustang Bio?: In the last twelve months, Mustang Bio insiders bought shares 1 times. They purchased a total of 247 shares worth more than $237.12. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 251 shares worth more than $240.92. The most recent insider tranaction occured on December, 30th when Director David Jin bought 247 shares worth more than $237.12. Insiders at Mustang Bio own 4.0% of the company. Learn More about insider trades at Mustang Bio.
Information on this page was last updated on 12/30/2025.

David Jin Insider Trading History at Mustang Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/30/2025	Buy	247	$0.96	$237.12	286

David Jin Buying and Selling Activity at Mustang Bio

Mustang Bio Company Overview

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors. The company develops MB-117 and MB-217, a gene therapy program for X-linked severe combined immunodeficiency, a rare genetic immune system condition in which affected patients do not live beyond infancy without treatment. The company also develops MB-106 CAR T cell program for B cell non-hodgkin lymphoma and chronic lymphocytic leukemia; MB-101 CAR T cell program for glioblastoma; MB-108, a next-generation oncolytic herpes simplex virus. It has license agreements with Nationwide Children's Hospital, CSL Behring; Mayo Clinic; Leiden University Medical Centre; SIRION Biotech GmbH. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts.

Today's Range

Now: $0.42

$0.38

$0.43

50 Day Range

MA: $0.54

$0.42

$0.61

2 Week Range

Now: $0.42

$0.38

$1.81

Volume

82,313 shs

Average Volume

108,399 shs

Market Capitalization

$3.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09